מאקליבן 400 מג 5 מל

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

AMOXICILLIN AS TRIHYDRATE; CLAVULANIC ACID AS POTASSIUM

Commercializzato da:

NOVARTIS ISRAEL LTD

Codice ATC:

J01CA04

Forma farmaceutica:

אבקה להכנת תרחיף

Composizione:

AMOXICILLIN AS TRIHYDRATE 400 MG / 5 ML; CLAVULANIC ACID AS POTASSIUM 57 MG / 5 ML

Via di somministrazione:

פומי

Tipo di ricetta:

מרשם נדרש

Prodotto da:

SANDOZ GmbH, AUSTRIA

Gruppo terapeutico:

AMOXICILLIN

Area terapeutica:

AMOXICILLIN

Indicazioni terapeutiche:

For the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused by beta-lactamase producing organisms which are susceptible to Amoxycillin + Potassium clavulanate and are resistant to other beta-lactam antibiotics.

Data dell'autorizzazione:

2015-03-31